Deals

U-M commits $20m to four spinouts
University of Michigan has committed an initial $2.75m in combined funding to MemryX, Ripple Science, GreenMark Biomedical, and Give and Take, and could invest as much as $20m altogether.
Neuspera restimulates $26m series B
Neuspera Medical has secured a $12m extension to bring its series B round to the targeted $26m close, with all investors from the first tranche returning.
Centrica gives Mixergy a whirl
The energy supplier's corporate venturing subsidiary has put an undisclosed sum into Oxford's smart water boiler spinout Mixergy.
Phylagen traces corporates for $14m series A
The environmental microbiome testing kit maker, based on Oregon research, has collected series A capital from investors including Western Digital Capital and 3M Ventures.
Glycotest captures $3m from Fosun Pharma
The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.
Passage Bio follows $116m series A trajectory
Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.
Vor roars to $42m series A
Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.
Sitka sets up $1.2m
UBC and CDRD spinout Sitka Biopharma has now lured $5.5m in total and is readying its bladder cancer treatment for initial clinical trials.

News Continued

Complion complies for $7m series B
Complion collected funding from investors including the multi-university-backed Ohio Innovation Fund for its regulatory compliance software platform catered to sites conducting clinical research.
OssDsign takes in $6.9m
Regenerative craniofacial implant manufacturer OssDsign has amassed $19.7m altogether as it prepares to take its products based on Karolinska and Uppsala university research into new markets.
Stanford-backed Eero connects to Amazon
Stanford-backed wifi system developer Eero has been picked up by Amazon after launching a product designed to provide high performance for devices including smart home products.
MIT helps SendFriend to $1.7m
Founded out of Massachusetts Institute of Technology, SendFriend has built a blockchain-powered online payment transfer platform that uses technology provided by fintech developer Ripple.
6Estates tends to series B round
6Estates had previously raised $2m of funding for its market intelligence products based on research from NUS and Tsinghua University.
Nuvaira shares $79m series E news
Nuvaira, based on research by a then-professor at Washington University School of Medicine, has closed a $79m funding round led by US Venture Partners.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Otsuka takes up Veryan’s acquisition offer
ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
Big deal: Novo pens $800m Ziylo acquisition
Ziylo, a spinout from University of Bristol that is working on a diabetes treatment, has been acquired by Novo Nordisk for a total that could exceed $800m.
test reg

Login